Codiak BioSciences said today that it has named former Alnylam Pharmaceuticals (NSDQ:ALNY) executive Dr. Benny Sorensen as vice president and head of clinical development.
Sorensen was Alnylam’s senior director of clinical research, leading the preclinical, clinical, regulatory and commercial strategies for hematology products. He also worked for Baxter (NYSE:BAX), advancing hematology therapies through Phase III pivotal development.
Get the full story at our sister site, Drug Delivery Business News.
The post Codiak BioSciences lures Alnylam vet Sorensen to lead clinical program appeared first on MassDevice.
from MassDevice http://ift.tt/2eaByr1
Cap comentari:
Publica un comentari a l'entrada